The American Cancer Society began its third major long-term follow-up study in 1982, enrolling approximately 1.2 million American men and women. This nationwide study, called Cancer Prevention Study II (CPS-II) – and its companion study, the CPS-II Nutrition Cohort – have yielded mountains of cancer insights – including numerous breast cancer insights. Learn more here.
Breast Cancer Research News
According to early research from an ACS grantee, pressing on tiny seeds taped to the ear just three times a day appears to greatly relieve pain and fatigue in women with breast cancer. Learn more here.
An ACS grantee has discovered that a gene switched on during puberty plays a critical role in the growth of ER-positive breast cancer cells. Learn how this could lead to targeted treatments for the most common form of breast cancer.
Early-stage research suggests there may be a new way to attack the toughest to treat breast cancer – triple negative.
When Mary-Claire King, Ph.D., now an American Cancer Society Research Professor at the University of Washington, discovered the genetic mutation that’s responsible for 5–10% of all breast cancers, the world was changed.
Breast cancer is most dangerous once it spreads elsewhere in the body. American Cancer Society-funded researcher Sandra McAllister, Ph.D., has discovered how some metastatic tumors develop and is now working to predict and prevent breast cancer’s spread.
Breast cancer researcher and breast cancer survivor Maryellen Brisbois says she got her sense of humor from her father. She is thankful for it because laughter, she says, is what helped get her and her family through her battle with breast cancer 7 years ago. Brisbois, a long-time practicing nurse, is now a professor and researcher and has uncovered unique insights into Latinas’ experience with breast cancer.
Disabling a protein overexpressed in half of breast cancers can stop tumor cells from multiplying. American Cancer Society-funded researcher Xiaoting Zhang, Ph.D., is trying to understand how this process works so that a drug can be developed to target the protein.
A combo drug therapy being tested for ER-positive breast cancer seems promising, yet an ACS grantee says "clinical trial results are not terribly impressive, and they really should be." Learn how a dosing time change might help.
For American women, breast cancer is one of the most common cancers, with 1 in 8 developing it in their lifetime. However, largely due to research discoveries, breast cancer in women declined in the early 2000s – after increasing for years. In addition, more women who do get breast cancer are now surviving it. These are the stories of 7 American Cancer Society-supported pioneers in breast cancer research who laid the foundation for breast cancer treatments that are saving lives today.
Dr. Yibin Kang, Ph.D., recipient of an American Cancer Society grant for functional genomics analysis of breast cancer dormancy and progression, recognized with an AACR Award for Outstanding Achievement in Cancer Research.
Learn more about American Cancer Society grantee Lee Ligon, PhD’s research on a molecule called Cadherin-23 and its relationship to the speed or extent of breast cancer metastasis.
American Cancer Society funded Researcher, Liana Castel, PhD conducts research at Vanderbilt University to better understand how joint pain affects women and strategies to help them continue taking aromatase inhibitor drugs.
Early-stage research suggests that it may be possible to stop the spread of breast cancer by changing the activity of molecules that are helping control whether certain genes get turned on or turned off. Learn more here.
Getting regular exercise is important for breast cancer survivors’ continued health. Physical activity can help lessen certain side effects of treatment, such as fatigue and depression, and has been shown to reduce risk of recurrence and improve survival. Few survivors, however, are getting enough exercise for it to be beneficial. Learn more here.
According to a study published online in the journal Nature Communications, the timing of when a patient receives certain cancer drugs may play a major role in the ultimate success of the treatment. Read more here.